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Introduction
Collaboration with industry focused on health improve-
ment is often viewed sceptically while existing examples
show a clear public health benefit. An approach was
adopted to explore the potential for establishing a colla-
borative with the World Health Organisation (WHO)
Patient Safety Programme.
Objectives
To establish a transparent WHO industry collaborative
for the benefit of patients, avoiding a focus on the
potential for commercial gain.
Methods
Between 2007 and 2012 a number of steps were under-
taken; 1) scoping of the potential for a collaborative, the
benefits to patients and to establish an aim, which
included desk research and multidisciplinary/agency dis-
cussions 2) interviews with WHO legal department 3)
an announcement to potential participants and informal
collaborative face-to-face interviews with interested par-
ties to strengthen a realistic patient-focused aim.
Results
A formal proposal was approved by WHO legal depart-
ment in 2012, which includes the overall aim of improv-
ing systems, education and research in order to provide a
public health benefit by reducing health care-associated
infections (HAI). Criteria for participation are clear and a
code of conduct and finance details are outlined. Imple-
mentation was approved as a protected web-based plat-
form to allow for targeted interaction, with a first year
aim of evaluating this. A total of 14 companies from
industries related to improving patient safety through
hand hygiene responded to the call from WHO and have
signed up to the code of conduct and provided finance.
An editorial and note for the media announcing the col-
laborative and its name ‘Private Organisations for Patient
Safety (POPS)’ was issued in 2012 to support transpar-
ency. One formal collaborative project has been
undertaken.
Conclusion
A transparent collaborative has been established and
funded which presents a clear public health benefit and
ensures that those involved are focused on corporate
social responsibility. As the plan for the first year is to
evaluate the platform method of working, this will inform
next steps as to whether it is possible to undertake fair
and equitable project working which can significantly
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